US EditionPublished • loading... • Updated
Eli Lilly stock price: $1.5 billion pill inventory puts April 10 FDA decision in spotlight
Summary by ts2.tech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Eli Lilly stock price: $1.5 billion pill inventory puts April 10 FDA decision in spotlight
Eli Lilly disclosed a $1.5 billion pre-launch inventory build for its experimental oral obesity drug orforglipron, up from $550 million last year. Shares closed at $1,040.00, up 0.2%. U.S. markets are closed Monday for Presidents Day, delaying the next session to Tuesday. The FDA decision on orforglipron is expected by April 10. The post Eli Lilly stock price: $1.5 billion pill inventory puts April 10 FDA decision in spotlight appeared first on …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
